Two days of work and studies begin in Rome in which over 100 young oncologists from all over the world, including developing countries, will participate. The objective is to discuss and promote the ability of young researchers to conceive and design new clinical studies to give a boost to independent research in oncology. The occasion is the second edition of the ‘Clinical Research Course’, promoted by the Italian Association of Medical Oncology (Aiom) in collaboration with the American Society of Clinical Oncology (Asco).
Aiom financially supported not only the enrollment in the course of all the selected participants, but also the travel expenses for some researchers coming in particular from more disadvantaged countries.
“We want to make young researchers protagonists in the planning of clinical studies – states Aiom president Francesco Perrone -. Teaching the methodology stimulates the ability to carry out independent research, which can mature especially in the late phases of trials, such as ‘real world‘ ones ‘. Unfortunately, from 2021 to 2022, clinical trials not sponsored by the pharmaceutical industry in our country decreased by approximately 7%.” Encouraging clinical trials, concludes Perrone, “is also important in order to reduce costs for the National Health Service when fully operational”.
breaking latest news © Copyright ANSA